Hugo Vrenken

17.3k total citations
177 papers, 9.7k citations indexed

About

Hugo Vrenken is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Hugo Vrenken has authored 177 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pathology and Forensic Medicine, 74 papers in Radiology, Nuclear Medicine and Imaging and 44 papers in Rheumatology. Recurrent topics in Hugo Vrenken's work include Multiple Sclerosis Research Studies (110 papers), Systemic Lupus Erythematosus Research (39 papers) and Advanced Neuroimaging Techniques and Applications (39 papers). Hugo Vrenken is often cited by papers focused on Multiple Sclerosis Research Studies (110 papers), Systemic Lupus Erythematosus Research (39 papers) and Advanced Neuroimaging Techniques and Applications (39 papers). Hugo Vrenken collaborates with scholars based in Netherlands, United Kingdom and United States. Hugo Vrenken's co-authors include Frederik Barkhof, Jeroen J.G. Geurts, Wiesje M. van der Flier, Philip Scheltens, Petra J. W. Pouwels, Chris H. Polman, Bernard M.J. Uitdehaag, Jonas A. Castelijns, Dirk L. Knol and Martijn D. Steenwijk and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain.

In The Last Decade

Hugo Vrenken

172 papers receiving 9.6k citations

Peers

Countries citing papers authored by Hugo Vrenken

Since Specialization

Citations

This map shows the geographic impact of Hugo Vrenken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Vrenken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Vrenken more than expected).

Fields of papers citing papers by Hugo Vrenken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Vrenken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Vrenken. The network helps show where Hugo Vrenken may publish in the future.

Co-authorship network of co-authors of Hugo Vrenken

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Vrenken. A scholar is included among the top collaborators of Hugo Vrenken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Vrenken. Hugo Vrenken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repeatability and reproducibility of brain age estimates in multiple sclerosis for three publicly available models 2025 ·Neuroimage Reports ·Len Bos, (unknown), James H. Cole, Eva Strijbis, Bastiaan Moraal, Joost P.A. Kuijer, Bernard M.J. Uitdehaag, Frederik Barkhof, Alle Meije Wink, Hugo Vrenken, Bas Jasperse	0
2	User requirements for quantitative radiological reports in multiple sclerosis 2025 ·European Radiology ·(unknown), (unknown), Len Bos, (unknown), Olga Ciccarelli, Jaume Sastre‐Garriga, Ferrán Prados, Joost P.A. Kuijer, Hugo Vrenken, Joep Killestein, Menno M. Schoonheim, Bastiaan Moraal, Tarek Yousry, Giuseppe Pontillo, Àlex Rovira, Eva Strijbis, Bas Jasperse, Frederik Barkhof, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data 2024 ·Multiple Sclerosis and Related Disorders ·(unknown), Eva Strijbis, (unknown), (unknown), Zoé L. E. van Kempen, Bas Jasperse, Hugo Vrenken, Joep Killestein, Menno M. Schoonheim, Martijn D. Steenwijk	2
4	Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a 2023 ·Journal of Neurology ·Hugo Vrenken, Marco Battaglini, (unknown), (unknown), Bernardo Corrêa de Almeida Teixeira, (unknown), Dominic Jack, Maria Pia Sormani, Bernard M.J. Uitdehaag, Adriaan Versteeg, Gıancarlo Comı, Ludwig Kappos, Nicola De Stefano, Frederik Barkhof	1
5	Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis 2023 ·Journal of Neurology ·(unknown), (unknown), Jos W. R. Twisk, Iman Brouwer, Joost P.A. Kuijer, (unknown), Hanneke E. Hulst, Joep Killestein, Frederik Barkhof, Hugo Vrenken, Petra J. W. Pouwels	2
6	Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses 2023 ·Neuroradiology ·(unknown), Houshang Amiri, Iman Brouwer, (unknown), Lidwine B. Mokkink, Frederik Barkhof, Hugo Vrenken, Joost P.A. Kuijer	15
7	Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study 2022 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), Iman Brouwer, Bastiaan Moraal, Joep Killestein, Paolo Gallo, Frederik Barkhof, Petra J. W. Pouwels, Hugo Vrenken	4
8	A unified model for reconstruction and R 2 * mapping of accelerated 7T data using the quantitative recurrent inference machine 2022 ·NeuroImage ·Chaoping Zhang, Dimitrios Karkalousos, Pierre‐Louis Bazin, Bram F. Coolen, Hugo Vrenken, Jan‐Jakob Sonke, Birte U. Forstmann, Dirk H. J. Poot, Matthan W.A. Caan	8
9	Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a 2022 ·European Journal of Neurology ·Marco Battaglini, Hugo Vrenken, (unknown), (unknown), (unknown), Adriaan Versteeg, Mark S. Freedman, Bernard M.J. Uitdehaag, Ludwig Kappos, Gıancarlo Comı, (unknown), Dominic Jack, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano	7
10	MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 2022 ·NeuroImage Clinical ·Nicola De Stefano, Marco Battaglini, Deborah Pareto, Rosa Cortese, Jian Zhang, Niels Oesingmann, Ferrán Prados, Maria A. Rocca, Paola Valsasina, Hugo Vrenken, Claudia A. M. Gandini Wheeler‐Kingshott, Massimo Filippi, Frederik Barkhof, Àlex Rovira	13
11	The sequence of structural, functional and cognitive changes in multiple sclerosis 2020 ·NeuroImage Clinical ·Iris Dekker, Menno M. Schoonheim, Vikram Venkatraghavan, A. J. C. Eijlers, Iman Brouwer, Esther E. Bron, Stefan Klein, Mike P. Wattjes, Alle Meije Wink, Jeroen J.G. Geurts, Bernard M.J. Uitdehaag, Neil P. Oxtoby, Daniel C. Alexander, Hugo Vrenken, Joep Killestein, Frederik Barkhof, Viktor Wottschel	23
12	Comparing lesion segmentation methods in multiple sclerosis: Input from one manually delineated subject is sufficient for accurate lesion segmentation 2019 ·NeuroImage Clinical ·(unknown), Iman Brouwer, (unknown), (unknown), Frederik Barkhof, Petra J. W. Pouwels, Hugo Vrenken	28
13	Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis 2019 ·Neurology ·A. J. C. Eijlers, Iris Dekker, (unknown), Kim Meijer, Hanneke E. Hulst, Petra J. W. Pouwels, Bernard M.J. Uitdehaag, Frederik Barkhof, Hugo Vrenken, Menno M. Schoonheim, Jeroen J.G. Geurts	60
14	White Matter Hyperintensity Volume and Cerebral Perfusion in Older Individuals with Hypertension Using Arterial Spin-Labeling 2016 ·American Journal of Neuroradiology ·Jan Willem van Dalen, Henk Mutsaerts, Aart J. Nederveen, Hugo Vrenken, Martijn D. Steenwijk, Matthan W.A. Caan, Charles B.L.M. Majoie, Willem A. van Gool, Edo Richard	52
15	A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context 2016 ·American Journal of Neuroradiology ·Loredana Storelli, Elisabetta Pagani, Maria A. Rocca, Mark A. Horsfield, Antonio Gallo, Alvino Bisecco, Marco Battaglini, Nicola De Stefano, Hugo Vrenken, David L. Thomas, Laura Mancini, Stefan Ropele, Christian Enzinger, Paolo Preziosa, Massimo Filippi	5
16	Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method 2016 ·PLoS ONE ·Veronica Popescu, Menno M. Schoonheim, Adriaan Versteeg, Nimisha Chaturvedi, Marianne A. Jonker, (unknown), (unknown), Bernard M.J. Uitdehaag, Frederik Barkhof, Hugo Vrenken	38
17	Automatic multiple sclerosis brain lesion localization and volumetry 2014 ·Multiple Sclerosis Journal ·Saurabh Jain, Dirk Smeets, Annemie Ribbens, Diana M. Sima, (unknown), Marita Daams, Martijn D. Steenwijk, Hugo Vrenken, Frederik Barkhof, Wim Van Hecke	13
18	Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease 2013 ·PLoS ONE ·Betty M. Tijms, (unknown), Hugo Vrenken, Alle Meije Wink, Willem de Haan, Wiesje M. van der Flier, Cornelis J. Stam, Philip Scheltens, Frederik Barkhof	17
19	Spinal cord lesions in patients with clinically isolated syndrome 2012 ·Neurology ·Madeleine H Sombekke, Mike P. Wattjes, Lisanne J. Balk, (unknown), Hugo Vrenken, Bernard M.J. Uitdehaag, Chris H. Polman, Frederik Barkhof	105
20	Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis 2011 ·Multiple Sclerosis Journal ·Alexandra Seewann, Hugo Vrenken, Evert‐Jan Kooi, Paul van der Valk, Dirk L. Knol, Chris H. Polman, Petra J. W. Pouwels, Frederik Barkhof, Jeroen J.G. Geurts	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact